The International Medica Foundation is working with the well established vaccine manufacturer IDT Biologika GmbH (http://www.idt-biologika.de/) located in Dessau-Rosslau, Germany to produce all of the RotaShield vaccine for its clinical trial in Ghana, Africa. All of the vaccine and placebo for the trial was manufactured in a state of the art vaccine manufacturing facility in Dessau-Rosslau, Germany.
IDT is an innovative, medium-sized companywith more than 85 years of experience inresearching, developing, manufacturing, and marketing of medicinal products including vaccines. Product manufacturing is done using the most modern technologies available in accordance with the Guidelines for Good Manufacturing Practice (GMP). IDT has been inspected by the FDA and EMEA.
In 2008, IDT Biologika received theFacility of the Year Awardfor Operational Excellence for its manufacturing site in Dessau-Rosslau, Germany. The Facility of the Year Awards, sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine recognizes state-of-the-art pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance quality and reduce the cost of producing medicines and the construction of new facilities for the manufacture of vaccines.
IDT Biologika GmbH based in Dessau-Rosslau, Germany, was originally established in 1921 in the pharmaceutical sector. IDT is wholly owned by the Klocke Group – known as contract manufacturers for the pharmaceutical and cosmetic industries on an international scale.
IDT develops, manufactures and markets vaccines in Germany and exports them throughout the world. Based on modern cGMP Standards, advanced technologies and in brand new facilities IDT provides contract manufacturing services for vaccines and pharmaceuticals for many pharmaceutical companies. IDT has a total of 500 highly-qualified employees.